4//SEC Filing
HICKLIN DANIEL J 4
Accession 0000899243-21-018089
CIK 0001785530other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:04 PM ET
Size
7.8 KB
Accession
0000899243-21-018089
Insider Transaction Report
Form 4
HICKLIN DANIEL J
DirectorSee Remarks
Transactions
- Award
Stock Option (right to buy)
2021-04-30+155,416→ 155,416 totalExercise: $16.00Exp: 2031-04-29→ Common Stock (155,416 underlying) - Award
Stock Option (right to buy)
2020-12-08+727,377→ 727,377 totalExercise: $4.77Exp: 2030-12-07→ Common Stock (727,377 underlying)
Footnotes (2)
- [F1]The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024.
- [F2]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001260929
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:04 PM ET
- Size
- 7.8 KB